Mosaic Family Wealth’s Supernus Pharmaceuticals SUPN Stock Holding History

Mosaic Family Wealth’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-123	Closed	-$5K	–	963
2017 Q2	$5K	Sell	123 -40	-25%	-$1.42K	﹤0.01%	591
2017 Q1	$5K	Hold	163	–	–	﹤0.01%	590
2016 Q4	$4K	Hold	163	–	–	﹤0.01%	598
2016 Q3	$4K	Hold	163	–	–	﹤0.01%	614
2016 Q2	$4K	Hold	163	–	–	﹤0.01%	630
2016 Q1	$2K	Hold	163	–	–	﹤0.01%	723
2015 Q4	$2K	Buy	+163	New	+$2.52K	﹤0.01%	707

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Mosaic Family Wealth's SUPN Position: Q3 2017 in Review

Mosaic Family Wealth sold out of Supernus Pharmaceuticals (SUPN) in Q3 2017, closing a stake of 123 shares — an estimated $5K sold.

Mosaic Family Wealth first reported a position in SUPN in Q4 2015 and held it in 7 quarters. The position peaked at $5K in Q2 2017. 275 funds tracked by Wall St. Rank hold SUPN as of Q3 2017.

Mosaic Family Wealth reported no remaining Supernus Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
Mosaic Family Wealth sold 123 Supernus Pharmaceuticals shares in Q3 2017, an estimated $5K.
Mosaic Family Wealth first reported a position in Supernus Pharmaceuticals in Q4 2015 and held it in 7 quarters.
Mosaic Family Wealth's Supernus Pharmaceuticals position peaked at $5K in Q2 2017.
275 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2017.

Based on Mosaic Family Wealth's 13F filing for Q3 2017, filed 27 Oct 2017.